KPIs & Operating Metrics(New)
Breakdown Of AssetsContractual ObligationsCost Of SalesEmployee StatisticsGross Margin %Gross Margin Annual %Gross ProfitGross Profit AnnualIncome Before Income TaxesNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Expense SegregationOpex As A % Of RevenueProperty, Plant & Equipment, Net BreakdownR&D As A %R&D SegregationRevenueRevenue By Customer TypeRevenue By Customer Type %Revenue By ProductRevenue By Product %Revenue By Product AnnualRevenue By Product Annual %Revenue By SegmentRevenue By Segment %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) Revenue (2016 - 2025)

Acadia Pharmaceuticals (ACAD) has 16 years of Revenue data on record, last reported at $284.0 million in Q4 2025.

  • For Q4 2025, Revenue rose 9.39% year-over-year to $284.0 million; the TTM value through Dec 2025 reached $1.1 billion, up 11.87%, while the annual FY2025 figure was $1.1 billion, 11.87% up from the prior year.
  • Revenue reached $284.0 million in Q4 2025 per ACAD's latest filing, up from $278.6 million in the prior quarter.
  • Across five years, Revenue topped out at $284.0 million in Q4 2025 and bottomed at $106.6 million in Q1 2021.
  • Average Revenue over 5 years is $187.9 million, with a median of $185.5 million recorded in 2023.
  • Peak YoY movement for Revenue: decreased 0.68% in 2022, then surged 73.75% in 2024.
  • A 5-year view of Revenue shows it stood at $130.8 million in 2021, then grew by 4.38% to $136.5 million in 2022, then soared by 69.27% to $231.0 million in 2023, then rose by 12.36% to $259.6 million in 2024, then increased by 9.39% to $284.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were $284.0 million in Q4 2025, $278.6 million in Q3 2025, and $264.6 million in Q2 2025.